DK1959991T3 - Terapeutisk vaccine - Google Patents

Terapeutisk vaccine

Info

Publication number: DK1959991T3
Authority: DK; Denmark
Prior art keywords: therapeutic vaccine; vaccine; therapeutic
Prior art date: 2005-12-12

Application number

DK06829455.2T

Other languages

English (en)

Inventor

Andrea Pfeifer

Claude Nicolau

Original Assignee

Ac Immune Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-12

Filing date

2006-12-08

Publication date

2013-06-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37836865&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1959991(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-08 Application filed by Ac Immune Sa filed Critical Ac Immune Sa

2013-06-17 Application granted granted Critical

2013-06-17 Publication of DK1959991T3 publication Critical patent/DK1959991T3/da

Links

229940021747 therapeutic vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Zoology (AREA)

DK06829455.2T 2005-12-12 2006-12-08 Terapeutisk vaccine DK1959991T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05027091		2005-12-12
EP06009098		2006-05-02
PCT/EP2006/011861 WO2007068411A2 (en)	2005-12-12	2006-12-08	Therapeutic vaccine

Publications (1)

Publication Number	Publication Date
DK1959991T3 true DK1959991T3 (da)	2013-06-17

Family

ID=37836865

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06829455.2T DK1959991T3 (da)	2005-12-12	2006-12-08	Terapeutisk vaccine

Country Status (24)

Country	Link
US (2)	US7807175B2 (da)
EP (2)	EP1959991B1 (da)
JP (2)	JP5249043B2 (da)
KR (2)	KR101236611B1 (da)
CN (1)	CN101330923B (da)
AR (1)	AR058327A1 (da)
AU (1)	AU2006326283B2 (da)
BR (1)	BRPI0619747B8 (da)
CA (1)	CA2633399C (da)
CR (1)	CR9994A (da)
DK (1)	DK1959991T3 (da)
EC (1)	ECSP088531A (da)
ES (2)	ES2407429T3 (da)
HK (1)	HK1127486A1 (da)
IL (1)	IL191397A (da)
MA (1)	MA30252B1 (da)
MY (1)	MY181173A (da)
NO (1)	NO346055B1 (da)
NZ (1)	NZ568384A (da)
RU (2)	RU2440824C2 (da)
SG (1)	SG172617A1 (da)
TW (1)	TWI537000B (da)
WO (1)	WO2007068411A2 (da)
ZA (1)	ZA200804918B (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10303974A1 (de)	2003-01-31	2004-08-05	Abbott Gmbh & Co. Kg	Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
KR101434935B1 (ko)	2005-11-30	2014-10-01	애브비 인코포레이티드	아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의용도
RU2442793C2 (ru)	2005-11-30	2012-02-20	Эбботт Лэборетриз	АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
EP2006381B1 (en)	2006-03-31	2016-02-03	Chugai Seiyaku Kabushiki Kaisha	Method for controlling blood pharmacokinetics of antibodies
EP2102165A2 (en)	2006-11-24	2009-09-23	AC Immune S.A.	N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's
US8455626B2 (en)	2006-11-30	2013-06-04	Abbott Laboratories	Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en)	2007-02-27	2008-09-04	Abbott Gmbh & Co. Kg	Method for the treatment of amyloidoses
CN101668525A (zh)	2007-03-01	2010-03-10	前体生物药物股份公司	谷氨酰胺酰环化酶抑制剂的新用途
EP2142514B1 (en)	2007-04-18	2014-12-24	Probiodrug AG	Thiourea derivatives as glutaminyl cyclase inhibitors
SI2202245T1 (sl)	2007-09-26	2016-10-28	Chugai Seiyaku Kabushiki Kaisha	Postopek modificiranja izoelektrične točke protitelesa preko aminokislinske substitucije v CDR
EP2106802A1 (en)	2008-04-02	2009-10-07	SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.	Modified peptides as synthetic vaccines in amyloid-associated disease
TW201447062A (zh)	2008-04-11	2014-12-16	Chugai Pharmaceutical Co Ltd	重複結合複數個抗原的抗原結合分子
EP3936122A1 (en)	2008-11-24	2022-01-12	Massachusetts Institute Of Technology	Methods and compositions for localized agent delivery
WO2010106127A2 (en) *	2009-03-18	2010-09-23	Ac Immune S.A.	Method for therapeutic use
UA107571C2 (xx) *	2009-04-03	2015-01-26		Фармацевтична композиція
KR100929372B1 (ko) *	2009-05-22	2009-12-02	고려대학교 산학협력단	아밀로이드 베타 단편을 유효성분으로 포함하는 돌연변이 ｓｏｄ1에 의한 ａｌｓ 예방 및 치료용 조성물
AT508638B1 (de) *	2009-08-21	2011-08-15	Affiris Ag	Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien
BR112012008346B1 (pt)	2009-09-11	2021-12-21	Vivoryon Therapeutics N.V.	Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
EP2311823A1 (en)	2009-10-15	2011-04-20	AC Immune S.A.	2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
EP2542549B1 (en)	2010-03-03	2016-05-11	Probiodrug AG	Inhibitors of glutaminyl cyclase
KR101790806B1 (ko)	2010-03-10	2017-11-20	프로비오드룩 아게	글루타미닐 사이클라제(ｑｃ, ｅｃ 2.3.2.5)의 헤테로사이클릭 억제제
US20110229556A1 (en) *	2010-03-19	2011-09-22	Massachusetts Institute Of Technology	Lipid-coated polymer particles for immune stimulation
US9149432B2 (en)	2010-03-19	2015-10-06	Massachusetts Institute Of Technology	Lipid vesicle compositions and methods of use
WO2011115684A2 (en)	2010-03-19	2011-09-22	Massachusetts Institute Of Technology	Lipid vesicle compositions and methods of use
MX360403B (es)	2010-04-15	2018-10-31	Abbvie Inc	Proteinas de union a amiloide beta.
RU2603008C2 (ru)	2010-04-16	2016-11-20	Ац Иммуне С.А.	Новые соединения для лечения заболеваний, связанных с амилоидными или амилоидоподобными белками
EP2377860A1 (en)	2010-04-16	2011-10-19	AC Immune S.A.	Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
EP2560953B1 (en)	2010-04-21	2016-01-06	Probiodrug AG	Inhibitors of glutaminyl cyclase
WO2012020124A1 (en)	2010-08-12	2012-02-16	Ac Immune S.A.	Vaccine engineering
EP2603524A1 (en)	2010-08-14	2013-06-19	AbbVie Inc.	Amyloid-beta binding proteins
CN103189050B (zh)	2010-10-26	2017-09-29	Ac免疫有限公司	包含通过疏水部分修饰的肽的基于脂质体的构建体
TWI812066B (zh)	2010-11-30	2023-08-11	日商中外製藥股份有限公司	具有鈣依存性的抗原結合能力之抗體
US20120148542A1 (en)	2010-12-10	2012-06-14	Lifeline Scientific, Inc.	Machine perfusion with complement inhibitors
ES2570167T3 (es)	2011-03-16	2016-05-17	Probiodrug Ag	Derivados de benzimidazol como inhibidores de glutaminil ciclasa
GB201113570D0 (en)	2011-08-05	2011-09-21	Glaxosmithkline Biolog Sa	Vaccine
KR20160099732A (ko) *	2011-09-23	2016-08-22	에이씨 이뮨 에스.에이.	백신 요법
KR102132041B1 (ko)	2012-04-05	2020-07-09	에이씨 이뮨 에스.에이.	인간화된 타우 항체
EP2970452A2 (en)	2013-03-15	2016-01-20	AC Immune S.A.	Anti-tau antibodies and methods of use
ES2904276T3 (es)	2013-09-27	2022-04-04	Massachusetts Inst Technology	Nanoestructuras de proteínas biológicamente activas sin vehículo
US10654807B2 (en) *	2013-12-20	2020-05-19	The University Of Kansas	Toll-like receptor 8 agonists
TWI617580B (zh) *	2014-12-19	2018-03-11	中外製藥股份有限公司	抗ｃ５抗體及使用方法
AU2015365168B2 (en)	2014-12-19	2021-08-05	Chugai Seiyaku Kabushiki Kaisha	Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
WO2017027843A1 (en)	2015-08-12	2017-02-16	Massachusetts Institute Of Technology	Cell surface coupling of nanoparticles
AU2017283480A1 (en)	2016-06-13	2019-01-24	Torque Therapeutics, Inc.	Methods and compositions for promoting immune cell function
KR102538749B1 (ko)	2016-08-05	2023-06-01	추가이 세이야쿠 가부시키가이샤	Il-8 관련 질환의 치료용 또는 예방용 조성물
WO2018081085A1 (en)	2016-10-25	2018-05-03	The Regents Of The University Of California	Methods of diagnosis and treatment of alzheimer's disease
WO2018204302A1 (en)	2017-05-01	2018-11-08	Vanderbilt University	Phosphorylated hexaacyl disaccharides (phads) for treating or preventing infections
JP7285828B2 (ja)	2017-09-05	2023-06-02	トルクセラピューティクス，インコーポレイテッド	治療用タンパク質組成物ならびにその作製および使用方法
EP3461819B1 (en)	2017-09-29	2020-05-27	Probiodrug AG	Inhibitors of glutaminyl cyclase
TWI827557B (zh)	2017-10-25	2024-01-01	美商健生醫藥公司	Ｔａｕ胜肽之組成物及其用途
CN108037277A (zh) *	2017-12-07	2018-05-15	中国兽医药品监察所	一种区分牛布鲁氏菌疫苗免疫与自然感染状态的方法
CN112165956A (zh) *	2018-04-10	2021-01-01	Ac免疫有限公司	抗Aβ治疗性疫苗
PE20201344A1 (es)	2018-04-10	2020-11-25	Ac Immune Sa	Vacunas terapeuticas anti-abeta
WO2020097155A1 (en)	2018-11-06	2020-05-14	Alsatech, Inc.	Cell-based gene therapy for neurodegenerative diseases
PH12021551876A1 (en)	2019-02-08	2022-05-23	Ac Immune Sa	Method of safe administration of phosphorylated tau peptide vaccine
CA3137884A1 (en)	2019-04-24	2020-10-29	Janssen Pharmaceuticals, Inc.	Heterologous administration of tau vaccines
WO2020234405A1 (en)	2019-05-21	2020-11-26	Ac Immune Sa	Anti-abeta vaccine therapy
WO2021207303A1 (en) *	2020-04-07	2021-10-14	Alsatech, Inc.	Immune stimulation against coronavirus infections
WO2024156912A1 (en)	2023-01-26	2024-08-02	Ac Immune Sa	Anti-abeta vaccine therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4847082A (en)	1987-01-21	1989-07-11	Robert Sabin	Method of treatment of Alzheimer's disease using phytic acid
US5262332A (en) *	1989-04-05	1993-11-16	Brigham And Women's Hospital	Diagnostic method for Alzheimer's disease: examination of non-neural tissue
US6787523B1 (en) *	1997-12-02	2004-09-07	Neuralab Limited	Prevention and treatment of amyloidogenic disease
KR20020073341A (ko) *	1999-11-29	2002-09-23	뉴로켐, 인크.	알츠하이머 및 아밀로이드 관련 질병의 예방 및 치료용 백신
DE10003992A1 (de) *	2000-01-29	2001-08-09	Bosch Gmbh Robert	Sensoranordnung
DK1317479T3 (da) *	2000-09-06	2009-11-23	Aventis Pharma Sa	Fremgangsmåder og sammensætninger for sygdomme, der er associeret med amyloidosis
EP1203614A1 (de)	2000-11-03	2002-05-08	Polymun Scientific Immunbiologische Forschung GmbH	Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
US6906169B2 (en) *	2001-05-25	2005-06-14	United Biomedical, Inc.	Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
AU2003231157C1 (en) *	2002-04-29	2009-02-26	Normoxys, Inc.	Inositol pyrophosphates, and methods of use thereof
WO2004058239A1 (en)	2002-12-24	2004-07-15	Neurochem (International) Limited	Therapeutic formulations for the treatment of beta-amyloid related diseases
US7521481B2 (en) *	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
CA2526083C (en) *	2003-06-02	2017-01-17	Evolutec Limited	Complement inhibitors
US20050123553A1 (en) *	2003-07-30	2005-06-09	Alon Monsonego	Amyloid beta-peptide and methods of use
AR051800A1 (es) *	2004-12-15	2007-02-07	Wyeth Corp	Anticuerpos a beta usados en mejorar la cognicion
EP1676859A1 (en) *	2004-12-30	2006-07-05	Pevion Biotech Ltd.	Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide
RU2015111675A (ru) *	2005-12-12	2015-08-10	Ац Иммуне Са	Специфические в отношении амилоида бета (а бета) 1-42 моноклональные антитела, обладающие терапевтическими свойствами

2006
- 2006-12-08 EP EP06829455A patent/EP1959991B1/en active Active
- 2006-12-08 JP JP2008544833A patent/JP5249043B2/ja active Active
- 2006-12-08 EP EP11172818.4A patent/EP2380588B1/en active Active
- 2006-12-08 KR KR1020127002472A patent/KR101236611B1/ko active Active
- 2006-12-08 WO PCT/EP2006/011861 patent/WO2007068411A2/en active Application Filing
- 2006-12-08 CN CN200680046697.XA patent/CN101330923B/zh active Active
- 2006-12-08 ES ES06829455T patent/ES2407429T3/es active Active
- 2006-12-08 SG SG2011036969A patent/SG172617A1/en unknown
- 2006-12-08 ES ES11172818.4T patent/ES2551604T3/es active Active
- 2006-12-08 BR BRPI0619747A patent/BRPI0619747B8/pt active IP Right Grant
- 2006-12-08 MY MYPI20081951A patent/MY181173A/en unknown
- 2006-12-08 KR KR1020087017128A patent/KR101152557B1/ko active Active
- 2006-12-08 NO NO20082216A patent/NO346055B1/no unknown
- 2006-12-08 AU AU2006326283A patent/AU2006326283B2/en active Active
- 2006-12-08 DK DK06829455.2T patent/DK1959991T3/da active
- 2006-12-08 CA CA2633399A patent/CA2633399C/en active Active
- 2006-12-08 RU RU2008128133/15A patent/RU2440824C2/ru active
- 2006-12-08 NZ NZ568384A patent/NZ568384A/en unknown
- 2006-12-12 AR ARP060105476A patent/AR058327A1/es not_active Application Discontinuation
- 2006-12-12 TW TW095146547A patent/TWI537000B/zh active
- 2006-12-12 US US11/637,607 patent/US7807175B2/en active Active
2008
- 2008-05-13 IL IL191397A patent/IL191397A/en active IP Right Grant
- 2008-05-20 CR CR9994A patent/CR9994A/es not_active Application Discontinuation
- 2008-06-05 ZA ZA2008/04918A patent/ZA200804918B/en unknown
- 2008-06-12 EC EC2008008531A patent/ECSP088531A/es unknown
- 2008-07-11 MA MA31115A patent/MA30252B1/fr unknown
2009
- 2009-04-14 US US12/386,140 patent/US8603487B2/en active Active
- 2009-06-09 HK HK09105160.4A patent/HK1127486A1/xx unknown
2011
- 2011-10-12 RU RU2011141308/15A patent/RU2011141308A/ru not_active Application Discontinuation
2013
- 2013-02-13 JP JP2013025108A patent/JP2013126993A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP1959991A2 (en)	2008-08-27
CN101330923B (zh)	2015-01-07
ES2551604T3 (es)	2015-11-20
WO2007068411A3 (en)	2007-08-23
NZ568384A (en)	2011-09-30
KR20120061049A (ko)	2012-06-12
TWI537000B (zh)	2016-06-11
ES2407429T3 (es)	2013-06-12
CA2633399C (en)	2016-01-26
BRPI0619747B1 (pt)	2019-03-26
KR101236611B1 (ko)	2013-03-04
CR9994A (es)	2008-09-22
KR20080084830A (ko)	2008-09-19
NO20082216L (no)	2008-08-22
US8603487B2 (en)	2013-12-10
AR058327A1 (es)	2008-01-30
CA2633399A1 (en)	2007-06-21
EP1959991B1 (en)	2013-03-20
RU2011141308A (ru)	2013-04-20
EP2380588A1 (en)	2011-10-26
RU2440824C2 (ru)	2012-01-27
CN101330923A (zh)	2008-12-24
TW200744630A (en)	2007-12-16
KR101152557B1 (ko)	2012-09-07
SG172617A1 (en)	2011-07-28
WO2007068411A2 (en)	2007-06-21
NO346055B1 (no)	2022-01-24
US20090238840A1 (en)	2009-09-24
JP2013126993A (ja)	2013-06-27
RU2008128133A (ru)	2010-01-20
MY181173A (en)	2020-12-21
AU2006326283A1 (en)	2007-06-21
ECSP088531A (es)	2008-07-30
AU2006326283B2 (en)	2012-01-19
BRPI0619747A2 (pt)	2011-10-18
MA30252B1 (fr)	2009-03-02
US7807175B2 (en)	2010-10-05
EP2380588B1 (en)	2015-08-05
HK1127486A1 (en)	2009-09-25
US20080267986A1 (en)	2008-10-30
ZA200804918B (en)	2011-10-26
BRPI0619747B8 (pt)	2021-05-25
JP5249043B2 (ja)	2013-07-31
JP2009519915A (ja)	2009-05-21
IL191397A (en)	2016-05-31

Publication	Publication Date	Title
DK1959991T3 (da)	2013-06-17	Terapeutisk vaccine
DK1968631T3 (da)	2015-06-15	Vaccine
ATE525088T1 (de)	2011-10-15	Kombinationstherapie
MA28609B1 (fr)	2007-05-02	Vaccins
DK3424932T3 (da)	2021-05-25	Bronophthalider til terapeutisk anvendelse
ATE450271T1 (de)	2009-12-15	Impfstoff
EP1868459A4 (en)	2010-01-27	FUNCTIONAL SHOE
CY2014030I1 (el)	2020-05-29	Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
DK1926496T3 (da)	2013-09-30	PCV-2-vaccine
FI20060708L (fi)	2007-05-01	Hierontalaite
MA28639B1 (fr)	2007-06-01	Vaccins
EP1908389A4 (en)	2011-03-02	MEDICAL CONTROLLER
EP1917040A4 (en)	2012-12-12	VACCINE VERSATILE
DE502005007353D1 (de)	2009-07-09	Zervikale zwischenwirbelprothese
NO20075628L (no)	2007-11-05	Farmasøytiske formuleringer
CR10571A (es)	2009-05-14	Vacuna virica recombinante
DK2035369T3 (da)	2014-10-06	Terapeutiske
DK1957073T3 (da)	2014-05-12	Lægemiddel
BRPI0613622A2 (pt)	2017-05-02	dispositivo médico
BRPI0607474A2 (pt)	2016-11-01	vacinação enriquecida com glicosido-alquila
MA28885B1 (fr)	2007-09-03	vaccins
DK2144905T3 (da)	2013-03-11	Terapeutiske midler
DE602006020744D1 (de)	2011-04-28	Fertigspritze
BRPI0820410A2 (pt)	2015-05-19	Lactans substituídos terapêuticos
BRPI0818598A2 (pt)	2017-05-16	agentes terapêuticos - 802